Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors
- PMID: 20225870
- DOI: 10.1021/ci9004749
Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors
Abstract
The viral NS5B RNA-dependent RNA-polymerase (RdRp) is one of the best-studied and promising targets for the development of novel therapeutics against hepatitis C virus (HCV). Allosteric inhibition of this enzyme has emerged as a viable strategy toward blocking replication of viral RNA in cell based systems. Herein, we describe how the combination of a complete computational procedure together with biological studies led to the identification of novel molecular scaffolds, hitherto untested toward NS5B polymerase. Structure based 3-D quantitative structure-activity relationship (QSAR) models were generated employing NS5B non-nucleoside inhibitors (NNIs), whose bound conformations were readily available from the protein database (PDB). These were grouped into two training sets of structurally diverse NS5B NNIs, based on their binding to the enzyme thumb (15 NNIs) or palm (10 NNIs) domains. Ligand based (LB) and structure based (SB) alignments were rigorously investigated to assess the reliability on the correct molecular alignment for unknown binding mode modeled compounds. Both Surflex and Autodock programs were able to reproduce with minimal errors the experimental binding conformations of 24 experimental NS5B allosteric inhibitors. Eighty-one (thumb) and 223 (palm) modeled compounds taken from literature were LB and SB aligned and used as external validation sets for the development of 3-D QSAR models. Low error of prediction proved the 3-D QSARs to be useful scoring functions for the in silico screening procedure. Finally, the virtual screening of the NCI Diversity Set led to the selection for enzymatic assays of 20 top-scoring molecules for each final model. Among the 40 selected molecules, preliminary data yielded four derivatives exhibiting IC(50) values ranging between 45 and 75 microM. Binding mode analysis of hit compounds within the NS5B polymerase thumb domain showed that one of them, NSC 123526, exhibited a docked conformation which was in good agreement with the thumb training set most active compound (6).
Similar articles
-
Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.J Chem Inf Model. 2014 Feb 24;54(2):539-52. doi: 10.1021/ci400644r. Epub 2014 Feb 5. J Chem Inf Model. 2014. PMID: 24460140
-
3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.J Chem Inf Model. 2008 Jan;48(1):42-55. doi: 10.1021/ci700266z. Epub 2007 Dec 13. J Chem Inf Model. 2008. PMID: 18076152
-
Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.Mol Divers. 2015 Aug;19(3):529-39. doi: 10.1007/s11030-015-9591-5. Epub 2015 Apr 11. Mol Divers. 2015. PMID: 25862642
-
Allosteric inhibition of the hepatitis C virus NS5B RNA dependent RNA polymerase.Infect Disord Drug Targets. 2006 Mar;6(1):31-41. doi: 10.2174/187152606776056724. Infect Disord Drug Targets. 2006. PMID: 16787302 Review.
-
Current perspective of HCV NS5B inhibitors: a review.Curr Med Chem. 2011;18(36):5564-97. doi: 10.2174/092986711798347234. Curr Med Chem. 2011. PMID: 22172066 Review.
Cited by
-
Machine Learning Data Augmentation as a Tool to Enhance Quantitative Composition-Activity Relationships of Complex Mixtures. A New Application to Dissect the Role of Main Chemical Components in Bioactive Essential Oils.Molecules. 2021 Oct 17;26(20):6279. doi: 10.3390/molecules26206279. Molecules. 2021. PMID: 34684861 Free PMC article.
-
Discovery and development of anti-HBV agents and their resistance.Molecules. 2010 Aug 27;15(9):5878-908. doi: 10.3390/molecules15095878. Molecules. 2010. PMID: 20802402 Free PMC article. Review.
-
In Silico Drug Discovery for Treatment of Virus Diseases.Adv Exp Med Biol. 2022;1368:73-93. doi: 10.1007/978-981-16-8969-7_4. Adv Exp Med Biol. 2022. PMID: 35594021
-
Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.PLoS One. 2016 Feb 4;11(2):e0148181. doi: 10.1371/journal.pone.0148181. eCollection 2016. PLoS One. 2016. PMID: 26845440 Free PMC article.
-
Structure-based discovery of pyrazolobenzothiazine derivatives as inhibitors of hepatitis C virus replication.J Med Chem. 2013 Mar 28;56(6):2270-82. doi: 10.1021/jm301643a. Epub 2013 Mar 7. J Med Chem. 2013. PMID: 23409936 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials